Quantcast

Latest Video Power Stories

2011-07-19 00:00:00

ZURICH, July 19, 2011 /PRNewswire/ -- Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has received Notice of Allowance for U.S.

2011-02-27 23:59:00

ZURICH, February 28, 2011 /PRNewswire/ -- - European Study is First Clinical Assessment of Kuros' Proprietary Synthetic Technology Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has treated the first patient in a pilot clinical trial investigating the safety and efficacy of KUR-023, its novel dural sealant product candidate....

2008-09-24 09:00:49

Switzerland-based Kuros Biosurgery has granted US-based Aeris Therapeutics an exclusive license in the field of lung volume reduction to certain patent rights Kuros exclusively licensed from the American Red Cross that cover the delivery of certain drugs in a fibrin sealant.


Word of the Day
saggar
  • A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
The word 'saggar' may come from 'safeguard'.
Related